Rajan Sharma Bhattarai1, Amitesh Das2, Rami M Alzhrani1, Dongjin Kang1, Sarit B Bhaduri3, Sai H S Boddu4. 1. College of Pharmacy and Pharmaceutical Sciences, The University of Toledo Health Science Campus, Toledo, OH 43614, USA. 2. Department of Mechanical, Industrial and Manufacturing Engineering, University of Toledo, Toledo, OH 43606, USA. 3. Department of Mechanical, Industrial and Manufacturing Engineering, University of Toledo, Toledo, OH 43606, USA; Department of Surgery (Dentistry), University of Toledo, Toledo, OH 43614, USA. Electronic address: sarit.bhaduri@utoledo.edu. 4. College of Pharmacy and Pharmaceutical Sciences, The University of Toledo Health Science Campus, Toledo, OH 43614, USA. Electronic address: sboddu@utnet.utoledo.edu.
Abstract
PURPOSE: The purpose of this work was to develop, characterize and compare electrospun nanofiber inserts (ENIs) and solvent cast polymeric inserts (SCIs) for ocular drug delivery. METHODS: ENI and SCI of 1%, 5% and 10% w/w dexamethasone were fabricated using a blend of poly-lactic acid (PLA) and poly-vinyl alcohol (PVA). Inserts were characterized for morphology, thickness, pH, drug content, drug crystallinity, in vitro drug release, sterility, dimethylformamide (DMF) and chloroform content, and cytotoxicity. RESULTS: The thickness of 1%, 5%, and 10% dexamethasone-loaded ENIs were found to be 50μm, 62.5μm, and 93.3μm, respectively, with good folding endurance. SCIs were brittle, with thickness values >200μm. Drug release rates from 1%, 5% and 10% ENIs were found to be 0.62μg/h, 1.46μg/h, and 2.30μg/h, respectively, while those from SCIs were erratic. DMF content in ENIs and SCIs were 0.007% w/w and 0.123% w/w, respectively, while chloroform was not detected. No cytotoxicity was observed from ENIs in cultured bovine corneal endothelial cells for up to 24h. CONCLUSION: We conclude that ENIs are better than SCIs and could be utilized as a potential delivery system for treating anterior segment ocular diseases.
PURPOSE: The purpose of this work was to develop, characterize and compare electrospun nanofiber inserts (ENIs) and solvent cast polymeric inserts (SCIs) for ocular drug delivery. METHODS: ENI and SCI of 1%, 5% and 10% w/w dexamethasone were fabricated using a blend of poly-lactic acid (PLA) and poly-vinyl alcohol (PVA). Inserts were characterized for morphology, thickness, pH, drug content, drug crystallinity, in vitro drug release, sterility, dimethylformamide (DMF) and chloroform content, and cytotoxicity. RESULTS: The thickness of 1%, 5%, and 10% dexamethasone-loaded ENIs were found to be 50μm, 62.5μm, and 93.3μm, respectively, with good folding endurance. SCIs were brittle, with thickness values >200μm. Drug release rates from 1%, 5% and 10% ENIs were found to be 0.62μg/h, 1.46μg/h, and 2.30μg/h, respectively, while those from SCIs were erratic. DMF content in ENIs and SCIs were 0.007% w/w and 0.123% w/w, respectively, while chloroform was not detected. No cytotoxicity was observed from ENIs in cultured bovine corneal endothelial cells for up to 24h. CONCLUSION: We conclude that ENIs are better than SCIs and could be utilized as a potential delivery system for treating anterior segment ocular diseases.
Authors: Sahar Awwad; Abeer H A Mohamed Ahmed; Garima Sharma; Jacob S Heng; Peng T Khaw; Steve Brocchini; Alastair Lockwood Journal: Br J Pharmacol Date: 2017-10-10 Impact factor: 8.739
Authors: Sarah A Stewart; Juan Domínguez-Robles; Victoria J McIlorum; Zoilo Gonzalez; Emilia Utomo; Elena Mancuso; Dimitrios A Lamprou; Ryan F Donnelly; Eneko Larrañeta Journal: Mol Pharm Date: 2020-08-03 Impact factor: 4.939
Authors: Mohamed Kchaou; Mohammed Alquraish; Khaled Abuhasel; Ahmad Abdullah; Ashraf A Ali Journal: Polymers (Basel) Date: 2021-03-16 Impact factor: 4.329